| 发明名称 |
COMBINATIONS OF CANCER THERAPEUTICS |
| 摘要 |
The invention relates to combinations of 4-[(S)-2-Azetidin-1-yl-1-(4-chloro-3- trifluoromethyl-phenyl)-ethylamino]-quinazoline-8-carboxylic acid amide and/or its physiologically acceptable salts and solvates, and an inhibitor of Her2, and the use of such combinations for the treatment of cancer. |
| 申请公布号 |
SG11201608189W(A) |
申请公布日期 |
2016.10.28 |
| 申请号 |
SG11201608189W |
申请日期 |
2015.03.09 |
| 申请人 |
MERCK PATENT GMBH |
发明人 |
HUCK, BAYARD R.;WILKER, ERIK;MACHL, ANDREAS;KALETA, REMIGIUSZ |
| 分类号 |
A61K39/395;A61K31/517;A61K45/06;A61P35/00 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
